The Société de Chimie Industrielle has extended an invitation to DCAT members to attend their November luncheon. The event will feature executive insights from guest speakers William S. Marth, President and CEO of AMRI, and Stephan Kutzer, Ph.D., CEO of Alcami. The program will discuss current issues and trends related to API development.
The API industry has gone through many phases over the years, but has always played a vital role in the development and production of pharmaceuticals. The growth of the pharmaceutical industry has helped to drive the growth of the API industry for many years. However, there also have been challenging periods of overcapacity, stresses related to competition from customers, the complexities related to the clinical trial requirements for drugs under development, and changes in drug technology and manufacturing methods. Our two panelists both have extensive industry experience and have worked for more than one company in the industry. They will share their insights about how the API industry has developed and what they see as the future trends, both good and bad, that the industry will be facing.
Use code "DCAT" at checkout.
The Société de Chimie Industrielle was founded in 1918 as The American Section of a Paris-based international organization. Today it operates as an independent New York-based Society with a mission to work with other chemical industry organizations and promote understanding of the chemical and allied industries. Activities include a monthly CEO forum, a scholarship program, and the International Palladium Medal awarded to an individual who has made outstanding contributions to the industry.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.